Drugs / Racemic nicotine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05962229 | Dec 2024 → May 2027 expected | nicotine dependence | University of California, San Francisco | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Racemic nicotine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05962229 ↗ |
| Route | Inhaled | “will vape e-liquid” NCT05962229 ↗ |